EP3569237
LYFJASAMSETNINGAR SEM INNIHALDA NATRÍUMNÍTRÍT
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.2.2010EP published:
26.5.2021EP application number:
19177863.8
EP translation filed:
28.6.2021Grant published:
15.8.2021EPO information:
European Patent Register
Max expiry date:
10.2.2030Expiry date:
10.2.2027Next due date:
28.2.2027
Title:
SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
Timeline
Today
11.2.2010EP application
26.5.2021EP Publication
28.6.2021Translation submitted
15.8.2021Registration published
10.2.2027Expires
Owner
Name:
Hope Medical Enterprises, Inc. d.b.a. Hope PharmaceuticalsAddress:
16416 N. 92nd Street 125, Scottsdale, AZ 85260, US
Inventor
Name:
SHERMAN, CraigAddress:
Scottsdale, AZ Arizona 85260, US
Name:
LEPINE, Anthony JamesAddress:
Greendale, WI Wisconsin 53129, US
Name:
SMITH, Catherine MarieAddress:
Grafton, WI Wisconsin 53024, US
Name:
WIRTZ, Kevin RobertAddress:
Eden Prairie, MN 55346, US
Name:
SCHULZE, ErichAddress:
Lake Elsinore, CA California 92530, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
151820 PDate:
11.2.2009Country:
US
Number:
224021 PDate:
8.7.2009Country:
US
Classification
Categories:
A61K 33/00, C01B 21/50, A61K 31/17, A61K 31/4418, A61K 31/4709, A61K 31/519, A61P 9/00, A61P 11/00, A61P 17/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 24.2.2022
Expires: 10.2.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 22.4.2023
Expires: 10.2.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 18.1.2024
Expires: 10.2.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 20.1.2025
Expires: 10.2.2026
Payer: Árnason Faktor ehf.
Number: 17
Paid: 30.1.2026
Expires: 10.2.2027
Payer: Árnason Faktor ehf.